Bone Biologics Corp. BBLG
0.50
0.01
2.04%
as of 25 Sep
- Market cap
- $1.4M
- P/E
- 0.0×
Follow BBLG
| Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
Current Ratio |
0.47 | 0.83 | 0.11 | 0.05 | 0.00 | 66.82 | 3.33 | 4.50 | 10.22 | 13.85 |
Net Debt/EBITDA |
(0.40) | (2.87) | (2.88) | (4.62) | 0.00 | 6.05 | 2.06 | 0.32 | 0.79 | 1.65 |
Debt/Assets |
1,249.89% | 0.00% | 864.80% | 36,753.25% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Debt/Equity |
(1.05) | (0.98) | (1.05) | (0.95) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating CF/Net income |
0.28 | 0.47 | 0.93 | 0.95 | 0.23 | 0.76 | 2.40 | 1.07 | 0.56 | 0.87 |
Capex/Depreciation |
0.00 | 0.00 | 0.00 | 0.00 | — | — | — | — | — | — |
Interest Coverage |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| 308.82% | 84.15% | 52.14% | 33.47% | 14.28% | 45.26% | (23.71%) | (202.15%) | (229.26%) | (70.17%) | |
| (3,457.87%) | (2,011.58%) | (851.43%) | (639.25%) | (11,848.70%) | (48.26%) | (19.57%) | (146.30%) | (192.78%) | (64.39%) | |
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | (1,662.67%) | (4,680.12%) |
Return on Tangible Assets |
3,232.01% | 4,242.84% | 51.53% | 625.42% | 13.33% | (24.50%) | (24.96%) | (307.90%) | (210.26%) | (57.81%) |
Average Days of Receivables |
— | — | — | — | — | — | — | — | — | 0.00 |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
— | — | — | 0.00% | — | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Free Cash Flow per Share |
(4.87) | (2.14) | (488.68) | (637.49) | (213.45) | (383.94) | (451.51) | (217.67) | (16.30) | (2.29) |
Cash per Share |
0.41 | 0.44 | 113.74 | 4.73 | 0.00 | 2,086.06 | 954.22 | 68.94 | 13.14 | 4.54 |
Shareholders Equity per Share |
(5.56) | (5.39) | (1,023.60) | (2,326.98) | (6,846.15) | 2,054.84 | 752.82 | 66.21 | 13.77 | 4.58 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
(5.56) | (5.39) | (1,023.60) | (2,326.98) | (6,846.15) | 2,054.84 | 752.82 | 66.21 | 13.77 | 4.58 |
Free Cash Flow |
(7.33) | (3.33) | (4.10) | (3.25) | (0.43) | (1.23) | (3.57) | (9.56) | (4.12) | (2.69) |
Working Capital |
(0.80) | (0.17) | (8.60) | (0.55) | (13.69) | 6.58 | 5.95 | 2.91 | 3.48 | 5.38 |
Net Current Asset Value |
(8.36) | (8.40) | (8.60) | (11.87) | (13.69) | 6.58 | 5.95 | 2.91 | 3.48 | 5.38 |
| Other line items | ||||||||||
Quick Ratio |
0.41 | 0.72 | 0.10 | 0.04 | 0.00 | 66.82 | 2.96 | 3.64 | 8.80 | 12.77 |
Depreciation/Fixed assets |
3.50 | 1.00 | 1.00 | 0.00 | — | — | — | — | — | — |
Cash ROIC |
(718.64%) | (635.29%) | (302.46%) | 621.05% | 3.12% | (9.27%) | (26.45%) | (161.06%) | (60.58%) | (25.12%) |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | — | — | — | — | — | — |
Average Days of Payables |
118,103.57 | 791,685.00 | 456,980.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | — | — | — | — | — | — |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating CF per Share |
(4.87) | (2.14) | (488.68) | (637.49) | (213.45) | (383.94) | (451.51) | (217.67) | (16.30) | (2.29) |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Payables |
0.22 | 0.22 | 0.17 | 0.13 | 0.30 | 0.28 | 0.10 | 0.23 | 0.37 | 0.40 |
Average Assets |
0.75 | 0.35 | 0.52 | 0.54 | 0.02 | 3.34 | 7.59 | 6.12 | 3.80 | 4.83 |
Average Common Equity |
(8.38) | (8.38) | (8.50) | (10.23) | (12.78) | (3.56) | 6.26 | 4.43 | 3.20 | 4.43 |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Columns are period end dates